| 1 |
Burden of Coronary Artery Disease and Peripheral Artery Disease: A Literature Review
Rupert Martin Bauersachs, Uwe Zeymer, J Brière et al. · Cardiovascular Therapeutics
Open access |
26 Nov 2019 |
451 |
| 2 |
Comparative Efficacy and Safety of Medical Treatments for the Management of Overactive Bladder: A Systematic Literature Review and Mixed Treatment Comparison
Khaled Maman, Samuel Aballéa, Jameel Nazir et al. · European Urology
Review |
21 Nov 2013 |
258 |
| 3 |
Humanistic burden in schizophrenia: A literature review
A. Millier, Ulrike H Schmidt, Matthias C. Angermeyer et al. · Journal of Psychiatric Research
Open access |
4 Apr 2014 |
246 |
| 4 |
Efficacy and Tolerability of Mirabegron Compared with Antimuscarinic Monotherapy or Combination Therapies for Overactive Bladder: A Systematic Review and Network Meta-analysis
Con J. Kelleher, Zalmaï Hakimi, Richard M. Zur et al. · European Urology
ReviewOpen access |
23 Apr 2018 |
228 |
| 5 |
Key drivers for market penetration of biosimilars in Europe
Cécile Rémuzat, Julie Dorey, Olivier Cristeau et al. · Journal of Market Access & Health Policy
Open access |
2017 |
216 |
| 6 |
Persistence and Adherence with Mirabegron versus Antimuscarinic Agents in Patients with Overactive Bladder: A Retrospective Observational Study in UK Clinical Practice
Christopher Reginald Chapple, Jameel Nazir, Zalmaï Hakimi et al. · European Urology
Open access |
11 Feb 2017 |
209 |
| 7 |
Advanced therapy medicinal products: current and future perspectives
Eve Hanna, Cécile Rémuzat, Pascal Auquier et al. · Journal of Market Access & Health Policy
Open access |
2016 |
169 |
| 8 |
The value of childhood combination vaccines: From beliefs to evidence
Khaled Maman, York Francis Zöllner, Donato Greco et al. · Human Vaccines & Immunotherapeutics
Open access |
15 Jun 2015 |
160 |
| 9 |
Annual public health and economic benefits of seasonal influenza vaccination: a European estimate
Emmanuelle Preaud, Laure Durand, Bérengère Macabeo et al. · BMC Public Health
Open access |
7 Aug 2014 |
146 |
| 10 |
Challenges in Research and Health Technology Assessment of Rare Disease Technologies: Report of the ISPOR Rare Disease Special Interest Group
Sandra Nestler-Parr, Daria A. Korchagina, Mondher Toumi et al. · Value in Health
Open access |
11 Apr 2018 |
143 |
| 11 |
Gene therapies development: slow progress and promising prospect
Eve Hanna, Cécile Rémuzat, Pascal Auquier et al. · Journal of Market Access & Health Policy
Open access |
2017 |
129 |
| 12 |
Measuring health-related quality of life in young children: how far have we come?
Nicola Germain, Samuel Aballéa, Mondher Toumi · Journal of Market Access & Health Policy
Open access |
2019 |
127 |
| 13 |
Subjective health status and health-related quality of life among women with Recurrent Vulvovaginal Candidosis (RVVC) in Europe and the USA
Samuel Aballéa, Florent Guelfucci, R Wagner et al. · Health and Quality of Life Outcomes
Open access |
2013 |
122 |
| 14 |
Outcomes-based reimbursement for gene therapies in practice: the experience of recently launched CAR-T cell therapies in major European countries
Jesper Jørgensen, Eve Hanna, Panos Kefalas · Journal of Market Access & Health Policy
Open access |
2020 |
119 |
| 15 |
Stigma in visible skin diseases – a literature review and development of a conceptual model
Nicola Germain, Matthias Augustin, Clément François et al. · Journal of the European Academy of Dermatology and Venereology
Open access |
15 Jan 2021 |
115 |
| 16 |
Quality of life is predictive of relapse in schizophrenia
Laurent Boyer, A. Millier, Emeline Perthame et al. · BMC Psychiatry
Open access |
9 Jan 2013 |
112 |
| 17 |
The real-life impact of vaccination on COVID-19 mortality in Europe and Israel
Katarzyna Jabłońska, Samuel Aballéa, Mondher Toumi · Public Health
Open access |
Sep 2021 |
107 |
| 18 |
Overview of external reference pricing systems in Europe
Cécile Rémuzat, Duccio Urbinati, Olfa Mzoughi et al. · Journal of Market Access & Health Policy
Open access |
2015 |
106 |
| 19 |
Treatment patterns, persistence and adherence rates in patients with type 2 diabetes mellitus in Japan: a claims-based cohort study
Rimei Nishimura, Haruka Kato, Koichi Kisanuki et al. · BMJ Open
Open access |
Mar 2019 |
104 |
| 20 |
Prevalence of hepatitis C infection among the general population and high-risk groups in the EU/EEA: a systematic review update
Ru Han, Junwen Zhou, Clément François et al. · BMC Infectious Diseases
ReviewOpen access |
23 Jul 2019 |
75 |
| 21 |
Cost-effectiveness analysis of pembrolizumab versus standard-of-care chemotherapy for first-line treatment of PD-L1 positive (>50%) metastatic squamous and non-squamous non-small cell lung cancer in France
CHRISTOS CHOUAID, Lionel Bensimon, Emilie Clay et al. · Lung Cancer
Open access |
23 Nov 2018 |
73 |
| 22 |
Equipercentile linking of scales measuring functioning and symptoms: Examining the GAF, SOFAS, CGI-S, and PANSS
Myrto T. Samara, Rolf R. Engel, A. Millier et al. · European Neuropsychopharmacology
|
20 Aug 2014 |
70 |
| 23 |
Burden of cytomegalovirus disease in solid organ transplant recipients: a national matched cohort study in an inpatient setting
Zalmaï Hakimi, Samuel Aballéa, Sameh Ferchichi et al. · Transplant Infectious Disease
Open access |
9 Jun 2017 |
69 |
| 24 |
Cost-effectiveness analyses using real-world data: an overview of the literature
Kevin Bowrin, J Brière, Pierre Lévy et al. · Journal of Medical Economics
Open access |
28 Feb 2019 |
65 |
| 25 |
Drug reformulations and repositioning in pharmaceutical industry and its impact on market access: reassessment of nomenclature
Susana Murteira, Zied Ghezaiel, Slim Karray et al. · Journal of Market Access & Health Policy
Open access |
2013 |
63 |
| 26 |
Evaluation of the treatment patterns and economic burden of dysmenorrhea in Japanese women, using a claims database
Sayako Akiyama, Erika Tanaka, Olivier Cristeau et al. · ClinicoEconomics and Outcomes Research
Open access |
May 2017 |
62 |
| 27 |
Attitudes and beliefs of the French public about schizophrenia and major depression: results from a vignette-based population survey
Matthias C. Angermeyer, A. Millier, Cécile Rémuzat et al. · BMC Psychiatry
Open access |
20 Nov 2013 |
61 |
| 28 |
Access to orphan drugs in Europe: current and future issues
Morgane Michel, Mondher Toumi · Expert Review of Pharmacoeconomics & Outcomes Research
|
27 Jan 2012 |
60 |
| 29 |
Supply-side and demand-side policies for biosimilars: an overview in 10 European member states
Cécile Rémuzat, Anna Kapusniak, Aleksandra Caban et al. · Journal of Market Access & Health Policy
Open access |
2017 |
59 |
| 30 |
Burden of Anemia in Chronic Kidney Disease Patients in Japan: A Literature Review
Tadao Akizawa, Hiroyuki Okumura, Ana Filipa Alexandre et al. · Therapeutic Apheresis and Dialysis
Open access |
18 Jul 2018 |
58 |
| 31 |
Direct healthcare cost of schizophrenia – European overview
Gábor László Kovács, Tímea Almási, A. Millier et al. · European Psychiatry
Open access |
2018 |
58 |
| 32 |
Public health and economic impact of seasonal influenza vaccination with quadrivalent influenza vaccines compared to trivalent influenza vaccines in Europe
M. Uhart, Hélène Bricout, Emilie Clay et al. · Human Vaccines & Immunotherapeutics
Open access |
11 May 2016 |
58 |
| 33 |
Expected cost effectiveness of high-dose trivalent influenza vaccine in US seniors
Ayman Chit, Julie Roïz, B. Briquet et al. · Vaccine
Open access |
11 Nov 2014 |
58 |
| 34 |
Market access agreements for pharmaceuticals in Europe: diversity of approaches and underlying concepts
Szymon Jarosławski, Mondher Toumi · BMC Health Services Research
Open access |
8 Oct 2011 |
55 |
| 35 |
Funding breakthrough therapies: A systematic review and recommendation
Emeline M. Hanna, Mondher Toumi, Claude Dussart et al. · Health Policy
Review |
2 Dec 2017 |
53 |
| 36 |
Effectiveness of onabotulinumtoxinA (BOTOX®) for the preventive treatment of chronic migraine: A meta-analysis on 10 years of real-world data
Michel Lantéri‐Minet, Anne Ducros, Clément François et al. · Cephalalgia
ReviewOpen access |
8 Sep 2022 |
52 |
| 37 |
Cultural differences in stigma surrounding schizophrenia: Comparison between Central Europe and North Africa
Matthias C. Angermeyer, Mauro Giovanni Carta, Herbert Matschinger et al. · The British Journal of Psychiatry
Open access |
11 Jan 2016 |
52 |
| 38 |
Drug reformulations and repositioning in the pharmaceutical industry and their impact on market access: regulatory implications
Susana Murteira, A. Millier, Zied Ghezaiel et al. · Journal of Market Access & Health Policy
Open access |
2014 |
51 |
| 39 |
Regenerative medicine regulatory policies: A systematic review and international comparison
Tingting Qiu, Eve Hanna, Monique Dabbous et al. · Health Policy
ReviewOpen access |
24 May 2020 |
50 |
| 40 |
Comparison of Inhaled Antibiotics for the Treatment of Chronic Pseudomonas aeruginosa Lung Infection in Patients With Cystic Fibrosis: Systematic Literature Review and Network Meta-analysis
J.S. Elborn, A.L. Vataire, Ayako Fukushima et al. · Clinical Therapeutics
ReviewOpen access |
Oct 2016 |
50 |
| 41 |
Development of the Alcohol Quality of Life Scale (AQoLS): a new patient-reported outcome measure to assess health-related quality of life in alcohol use disorder
Amandine Luquiens, Diane Whalley, SR Crawford et al. · Quality of Life Research
|
19 Nov 2014 |
50 |
| 42 |
An Assessment of the Expected Cost-Effectiveness of Quadrivalent Influenza Vaccines in Ontario, Canada Using a Static Model
Ayman Chit, Julie Roïz, Samuel Aballéa · PLoS ONE
Open access |
29 Jul 2015 |
50 |
| 43 |
Comparison of NITAG policies and working processes in selected developed countries
Walter Ricciardi, Mondher Toumi, Catherine Weil-Olivier et al. · Vaccine
Open access |
23 Sep 2014 |
47 |
| 44 |
Continuum beliefs and attitudes towards people with mental illness: Results from a national survey in France
Matthias C. Angermeyer, A. Millier, Cécile Rémuzat et al. · International Journal of Social Psychiatry
|
24 Jul 2014 |
46 |
| 45 |
A critical literature review of health economic evaluations of rotavirus vaccination
Samuel Aballéa, A. Millier, Sibilia Quilici et al. · Human Vaccines & Immunotherapeutics
Open access |
29 May 2013 |
46 |
| 46 |
Family caregiving in dementia and its impact on quality of life and economic burden in Japan-web based survey
Ataru Igarashi, Ayako Fukuda, Lida Teng et al. · Journal of Market Access & Health Policy
Open access |
2020 |
44 |
| 47 |
Filling the gap in CNS drug development: evaluation of the role of drug repurposing
Aleksandra Caban, K. Pisarczyk, Kenneth Kopacz et al. · Journal of Market Access & Health Policy
Open access |
2017 |
43 |
| 48 |
Do payers value rarity? An analysis of the relationship between disease rarity and orphan drug prices in Europe
Goran Medić, Daria A. Korchagina, Katherine Eve Young et al. · Journal of Market Access & Health Policy
Open access |
2017 |
43 |
| 49 |
Patient survey to identify reasons for non-adherence and elicitation of quality of life concepts associated with immunosuppressant therapy in kidney transplant recipients
Francis Shupo, Sophie Dam, Natalia Hawken et al. · Patient Preference and Adherence
Open access |
2016 |
42 |
| 50 |
Achievement Rates for Low-Density Lipoprotein Cholesterol Goals in Patients at High Risk of Atherosclerotic Cardiovascular Disease in a Real-World Setting in Japan
Hironobu Mitani, Kota Suzuki, Junya Ako et al. · Journal of Atherosclerosis and Thrombosis
Open access |
16 Mar 2023 |
41 |